Our Recommendations
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
- Monkeypox: Caring for the skin (2022)
- Landscape of Therapeutics licensed or under development for Mpox (2024)
- Landscape of vaccines licensed or under development for Mpox (2024)
New Publications
- Considerations for wastewater and environmental surveillance for monkeypox virus: interim guidance, 25 November 2024 (2024)
- Protecting Kids: Mpox Guidelines for Schools (2024)
- Strategic Framework for Enhancing Prevention and Control of mpox, 2024-2027 (2024)
- Multi-country outbreak of mpox, External situation report #42- 9 November 2024 (2024)
- Mpox Daily situation report Situation update 12-November-2024 (2024)
Filter
896
Featured
Recommendations
154
New Publications
238
Language
Document type
No document type
437
Guidelines
121
Training Material
51
Manuals
43
Situation Updates
41
Fact sheets
40
Online Courses
38
Studies & Reports
37
Infographics
28
Strategic & Response Plan
26
Resource Platforms
22
Videos
11
Dashboards/Maps
1
Countries / Regions
Congo, Democratic Republic of
32
Brazil
27
Nigeria
23
Guinea
23
Sierra Leone
21
Africa
21
Madagascar
21
Liberia
20
Latin America and the Carribbean
19
Senegal
18
Burkina Faso
17
Rwanda
16
Global
15
Côte d’Ivoire / Ivory Coast
14
Germany
13
Angola
12
Mozambique
11
Western and Central Europe
11
Russia
11
Mali
11
West and Central Africa
9
India
9
Uganda
8
Indonesia
8
Ghana
7
Syria
7
Ethiopia
7
East and Southern Africa
6
South Africa
6
Somalia
6
Paraguay
5
Portugal
5
Yemen
5
Chad
5
South Sudan
5
Colombia
4
Kenya
4
Togo
4
Burundi
4
Peru
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Argentina
4
Vietnam
4
Sri Lanka
4
China
3
Cameroon
3
Niger
3
Central African Republic
3
Nepal
2
Afghanistan
2
Zimbabwe
2
USA
2
Asia
2
Venezuela
2
Bolivia
2
Bangladesh
2
Serbia
1
Turkey
1
Benin
1
Gambia
1
Iran
1
Kyrgyzstan
1
Philippines
1
Italy
1
Haiti
1
Dominican Republic
1
Guinea-Bissau
1
Croatia
1
Tanzania
1
Saudi Arabia
1
Western Pacific Region
1
Turkmenistan
1
Japan
1
United Kingdom
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Sudan
1
Honduras
1
Zambia
1
Ecuador
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Disaster Preparedness
56
MPOX - Monkeypox
49
Disease Prevention & Control
46
Infection Control & Prevention (IPC)
39
Guidelines
36
Hand Hygiene
32
Vaccine-preventable Diseases
22
Public Health
21
Online Courses & Platforms
21
Yellow Fever
21
Other
19
Yersinia pestis (Plague)
18
Humanitarian Crisis
17
General Guidelines
15
COVID-19
13
Water, Sanitation and Hygiene (WASH)
13
Dengue
12
Humanitarian Aid
11
Diarrhoeal Disease/Cholera
11
Policies
11
WASH
11
Capacity Building
10
Virology
9
Statistics
9
Key Resources
9
Clinical Training
8
Hemorrhagic Fever
8
Needs Assessment
8
Monitoring & Evaluation
7
Humanitarian Aid
7
Studies & Reports
7
General Guidelines
7
Health Systems
7
Vector Control
6
Public Health
6
Emergency Health Kits
5
Bacteriology
5
NTDs & Others
5
Zika
4
x MEDBOX Issue Brief & Annual Reports x
4
Pediatrics
4
Surgery & Anaesthesia
4
Laboratory Quality Assurance
4
Paediatrics
3
COVID-19
3
Mobile Training Tools & Apps
3
Clinical Guidelines
3
Community Health
3
Waste Management
3
Quality Control & Assurance
3
Communicable Diseases
3
Protection & Security
3
Water
3
Communicable Diseases
2
Sanitation
2
Project Cycle Management
2
Laboratory Waste
2
Capacity Building
2
Diarrhoea
2
Respiratory Infections
2
Online Courses Platforms
1
Videos
1
Maternal & Child Health
1
IEC Material
1
Countries
1
NCD
1
Medical Devices & Equipment
1
Policies & Guidelines HIV & TB
1
Women & Child Health
1
Information, Education and Communication (IEC)
1
Non-communicable Diseases
1
Hygiene Promotion
1
Toolboxes
Public Health
112
MPOX - Monkeypox
91
Surveillance
84
IPC
69
Ebola Prevention & Control
55
Key Resources
54
Training
54
MPOX - Monkeypox
49
Capacity Building
43
MPOX -Monkeybox Prevention & Control
38
Influenza Prevention & Control
37
Cholera Prevention & Control
33
Risk Communication & Community Engagement
33
Hand Hygiene
29
Communication & Training
26
Dengue Prevention & Control
25
Plague Prevention & Control
23
Zika Prevention & Control
22
Yellow Fever Prevention & Control
20
Laboratory Guidance
19
Plague Situation Reports
17
Yellow Fever Situation Report
17
Situation Reports, others
17
Early Warning
16
Cholera
16
Other Resources
15
Chikungunya Prevention & Control
13
Early Warning
12
Influenza
12
Meningitis Prevention & Control
10
Dengue
10
Chikungunya
9
Yellow Fever
8
Cholera Situation Reports
7
Plague
7
Ebola
7
GO pre-deployment training
7
Zika
7
Marburg Virus Situation Reports
7
European Resource
5
Clinical Guidelines
3
Covid-19 TOOLBOX
2
Internet Resources
1
interim guidance, 25 November 2024
The safety of children is a top concern for parents and school authorities in the current mpox outbreak, as those
under 15 face elevated risks, particularly in the hardesthit Northwestern and Eastern regions of the Democratic Republic of the Congo.
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani...
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
Situation Update
On 14 August 2024, the Director-General of the World Health Organization determined that the upsurge of mpox in a growing number of countries in Africa constitutes a new public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005)
Situation Report
On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedi...
On 27 September 2024, the Ministry of Health of Rwanda confirmed the country’s first outbreak of Marburg virus disease (MVD), with health-care workers in Kigali particularly affected. While sporadic outbreaks have occurred in various parts of Africa since the first recognized cases in 1967, this o...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Du 09 janvier au 08 avril 2024, le Congo a confirmé 19 cas de Mpox dans 04 départements, à savoir : 14 cas dans la Cuvette, 02 cas dans la Likouala, 02 cas dans les Plateaux et 01 cas à Pointe-Noire. Au regard de cette situation, le Gouvernement de la République, via le Ministère de la Santé ...
Uganda confirmed the first cases of mpox on 24 July 2024 following the confirmation of two case-patients from Kasese District, Bwera Hospital by the Uganda Virus Research Institute (UVRI) through a routine sentinel surveillance system. Cumulatively, 80 confirmed cases of mpox have been registered.
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
Flyer German
22 September 2024
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per...
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ...
Mpox is a zoonotic disease caused by a double-stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family. The disease presents with symptoms similar to smallpox but with a lesser severity. It was first discovered in 1958 when two outbreaks of a poxlike disease occurred in co...
There has been a global outbreak of mpox since 2022; this outbreak has been caused by the strain of mpox virus called Clade 2 and has affected around 116 countries worldwide. The current surge in cases is being driven by the rapid spread of a different strain – Clade 1b – which is predominantly ...
